Key result
Anxiety disorders affect 18% of T2D outpatients, linked to female gender, complications, and poor glycemic control.
Why the study?
Information on the specific types and prevalence of anxiety disorders in people with type 2 diabetes mellitus was limited, despite their known impact on diabetes outcomes and quality of life.
What is the prevalence and what are the correlates of anxiety disorders in people with type 2 diabetes mellitus?
Population
3170 people aged 18-65 years with type 2 diabetes treated in outpatient settings across 15 countries
Design
Multinational cross-sectional study
Authors
Loading...
Anxiety disorders affect ~1 in 5 with T2DM; supports screening consideration but leaves causal outcome links open for prospective trials.
Cross-Sectional (n=3,170)
Yes
What is the prevalence and what are the correlates of anxiety disorders in people with type 2 diabetes mellitus?
Anxiety disorders are highly prevalent (18%) in patients with type 2 diabetes, particularly among women and those with complications or poor glycaemic control, highlighting the need for psychiatric screening.
Chaturvedi et al. (2019) conducted a cross-sectional in Type 2 diabetes mellitus (n=3,170). Type 2 diabetes mellitus was evaluated on Prevalence of anxiety disorders. In outpatients with type 2 diabetes, the overall prevalence of anxiety disorders was 18%, and was significantly associated with female gender, diabetic complications, and poorer glycaemic control.
Synapse has enriched 4 closely related papers on similar clinical questions. Consider them for comparative context: